Anzeige
Mehr »
Login
Sonntag, 30.06.2024 Börsentäglich über 12.000 News von 684 internationalen Medien
Breaking News! Der "13.000%-PODD-Moment" für NuGen Medical?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
337 Leser
Artikel bewerten:
(1)

Bronchoscopy Market to Reach $4.88 Bn, Globally, by 2030 at 6.3% CAGR: Allied Market Research

- Increase in prevalence of respiratory diseases and growth in demand for minimally invasive surgery, drive the growth of the global bronchoscopy market.

PORTLAND, Ore., Aug. 10, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Bronchoscopy Market by Product (Endoscope, Visualization & Documentation Systems, Accessories, and Other Products), Usability (Disposable Equipment and Reusable Equipment), Application (Bronchial Diagnosis and Bronchial Treatment), and End User (Hospitals and Ambulatory Surgical Centers & Clinics): Global Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the global bronchoscopy industry garnered $2.55 billion in 2020, and is projected to generate $4.88 billion by 2030, growing at a CAGR of 6.3% from 2021 to 2030.

Allied_Market_Research_Logo

Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/10903

Prime determinants of growth

Increase in prevalence of respiratory diseases, growth in demand for minimally invasive surgery, and technological advancement in bronchoscopy propel the growth of the global bronchoscopy market. However, lack of trained physicians and pulmonologists restricts the market growth. On the other hand, growing prospects in emerging markets present new opportunities in the coming years.

Covid-19 Scenario

  • Bronchoscopy and related procedures have explicitly been affected during the outbreak of COVID-19 pandemic.
  • The non-emergency treatments were either put on hold or suspended temporarilyduring the initial phase of covid-19. Also, the facilities were majorly focused on the treatment of covid patients, due to which the clinics and health centers were instructed to be closed.
  • Nevertheless, the situations are coming under control as most regions are witnessing slight decrease in new cases. In addition, the initiation of vaccination drives across several regions has further assisted the market to get revived.

Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/10903

The endoscope segment to lead in terms of revenue throughout the forecast period

By product, the endoscope segment held the highest market share in 2020, contributing to nearly three-fifths of the total share of the global bronchoscopy market, and is estimated to continue to lead in terms of revenue throughout the forecast period. In addition, this segment is also anticipated to witness the fastest CAGR of 6.9% from 2021 to 2030. This is due to high cost of bronchoscopes compared to the imaging systems and accessories, rise in prevalence of lung cancer, and technological advancements.

The bronchial treatment segment to maintain its leadership status by 2030

By application, the bronchial treatment segment accounted for the largest market share, holding nearly three-fourths of the global bronchoscopy market in 2020, and is expected to maintain its leadership status by 2030. Furthermore, the segment is also projected to manifest the largest CAGR of 6.5% during the forecast period. This is attributed to surge in prevalence of target diseases, which will drive the demand for bronchoscopy equipment in therapeutic procedures. Also, growth in prevalence of respiratory diseases contributes to the growth of the bronchoscopy market.

North America to maintain its dominant share during the forecast period

By region, North America contributed to the highest share of the global bronchoscopy market, accounting for more than one-third of the total share in 2020, and will maintain its dominant share during the forecast period. This is attributed to rise in the incidence and prevalence of chronic respiratory diseases, favorable reimbursement scenario in the US, and rising incidence of lung cancer in Canada. However, Asia-Pacific is estimated to register the fastest CAGR of 7.3% from 2021 to 2030. This is due to factors such as the surge in number of hospitals, developing healthcare infrastructure, rise in healthcare expenditure, increase in geriatric population, and the presence of a large patient population.

Leading market players

  • Olympus Corporation
  • Karl Storz
  • Fujifilm Holdings Corporation
  • Ambu A/S
  • Boston Scientific Corporation
  • Medtronic
  • Johnson & Johnson
  • Hoyo Corporation
  • Richard Wolf GmbH
  • Cook Medical

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter

Get more information: https://www.alliedmarketresearch.com/library-access

We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.

Trending Reports in Healthcare Industry:

Monoclonal Antibodies Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Single Cell Multiomics Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Fertility Test Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Digital Health Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Blood Purification Equipment Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Contraceptive Drugs Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

Scaffold Technology Market - Global Opportunity Analysis and Industry Forecast, 2019-2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

© 2021 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.